Partex
PrivateLast Round
Series C
Apr 25, 2019
Total Funding Raised
$3M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
Partex operates in Healthcare & Life Sciences and is based in Eschborn. Its latest recorded funding round was a Series C round in April 2019.
Partex is a biotechnology company that develops an advanced artificial intelligence and blockchain technology platform designed to support all stages of drug development from pipeline to market.
Sector
Healthcare & Life Sciences
Verticals
Drug Discovery, Biotechnology, Medical AI, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Revenue Share, Subscription SaaS, Marketplace Commission, Freemium
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Partex Comparables
Compare Partex with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Delta4 | 81% | |
| Healx | 79% | |
| Insilico Medicine | 79% |
For institutional investors. Book with your work email.
Partex Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Apr 25, 2019 | ||||
| Pre Seed | Dec 22, 2016 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
Partex Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Block.one | Series C |
| HCS Beteiligungsgesellschaft | Pre Seed |
| Heliad AG | Series C |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 22, 2026
Open roles increased to 30, 2.3x the trailing average.
- Dec 7, 2025
Monthly visitors grew 95% MoM, reaching 6.7K.
For institutional investors. Book with your work email.
Partex Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Partex's valuation, stock price, and market status.
Is Partex a public or private company?
Partex is a private company.
What is the current stock price of Partex?
Partex is a private company, so its shares have no public market price. Caplight tracks Partex's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Partex worth (valuation)?
Valuation information for Partex is not publicly available.
Can I buy Partex stock?
Partex shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Partex's last funding round?
Partex's most recent funding round was Series C on April 25, 2019.
Who are the main investors in Partex?
Key investors in Partex include HCS Beteiligungsgesellschaft, Heliad AG.
Will Partex IPO soon?
No public IPO plans have been announced for Partex.
How can I track Partex secondary market activity?
Caplight tracks bids, offers, and trades in Partex's shares on secondary markets.